Copan Italia is recalling approximately 122,850 units of their 1ml DTT liquid phase treatment reagents used for processing respiratory specimens. These reagents are used in laboratory settings to liquify or fluidify specimens for analysis and were distributed both in bulk and as part of systems compatible with the WASP (Walk-Away Specimen Processor). The manufacturer is initiating this recall because the functionality of the treatment reagent cannot be guaranteed, which could lead to laboratory errors.
The failure of the treatment reagent to properly liquify respiratory specimens may interfere with the fluidification process required for laboratory analysis. This could potentially result in inaccurate test results or delays in medical diagnosis for patients with respiratory conditions.
Compatible with Copan's WASP (Walk-Away Specimen Processor for Microbiology) System
“Front label, DEVI Cinnamon Powder, 3.5 oz.”
“Back label, Nutrition Facts”
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · FDA Press Release · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.